ICAR Research Data Repository for Knowledge Management
In vitro antiviral efficacy of pleconaril and ribavirin on foot-and-mouth disease virus replication.
KRISHI: Publication and Data Inventory Repository
View Archive Info| Field | Value | |
| Title |
In vitro antiviral efficacy of pleconaril and ribavirin on foot-and-mouth disease virus replication.
|
|
| Creator |
Soumajit S, Tamil Selvan RP, Bhanuprakash V.
|
|
| Subject |
Cytopathic inhibition assay; Foot-and-mouth disease virus; PCR/real time PCR; Pleconaril; Ribavirin; sELISA.
|
|
| Description |
Not Available
Antiviral therapy is a promising strategy to control acute viral infections. FMDV causes an acute infection and the vaccination provides a protective immunity 7 days post immunization. If the infection is uncontained, then it affects the entire herd. In such circumstances, if antiviral drug is administered the infection can be checked in a herd. Ribavirin is known to cure persistently infected BHK21 cells with FMD virus. However, there have been no systematic studies on antiviral activity of ribavirin against FMDV at different time points with the application of ELISA, PCR or real-time PCR. Pleconaril is known to inhibit enteroviruses and rhinoviruses but has not been explored on FMDV. Hence, the present study evaluates the in vitro antiviral efficacy of pleconaril and ribavirin on FMDV replication. The maximum non-toxic concentrations (MNTC) of pleconaril and ribavirin for BHK21 cells respectively were 7.81 μg/50 μL and 15.62 μg/50 μL. Thus, drug concentrations below MNTC were tested for their antiviral activity against serial tenfold diluted FMDV O, A and Asia 1 serotypes. Pleconaril did not inhibit FMDV serotype O replication at 7.5 μg/50 μL based on CPE inhibition assay and this was further confirmed using sandwich ELISA, PCR/real-time PCR. On the other hand, ribavirin at 15.62 μg/50 μL inhibited the in vitro replication of FMDV O, A and Asia 1 and the inhibition was confirmed by serotype specific sandwich ELISA, PCR and real-time PCR assays. The inhibition was directly proportional to the concentration of ribavirin. Therefore, ribavirin could be explored for its in vivo efficacy as a potential therapeutic in the prevention of early spread of FMDV infection in a herd. Not Available |
|
| Date |
2023-05-12T05:59:14Z
2023-05-12T05:59:14Z 2019-12-05 |
|
| Type |
Research Paper
|
|
| Identifier |
Not Available
Not Available http://krishi.icar.gov.in/jspui/handle/123456789/77197 |
|
| Language |
English
|
|
| Relation |
Not Available;
|
|
| Publisher |
Springer
|
|